Somatostatin receptor pet radiopharmaceuticals
Ended Definitive Contract Awarded Last action
- Contract number
- 36C24724C0060
- Awardee
-
RLS (USA) Inc. UEI UA3GDUKRYSM5
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $508,751
Award facts
- Opportunity
-
- Q527--Somatostatin Receptor PET Radiopharmaceuticals Solicitation · 36C24724Q0663 · Posted May 22, 2024
- Contract value 36% obligated
-
- $810,551.12 Current, with exercised options
- $1,414,152.24 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q527 Medical- Nuclear Medicine
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Decatur, GA 30033, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$62,451 | |
| Exercise an Option | $301,801 | |
| Other Administrative Action | $121,500 | |
| Original award | $147,901 |
About this award
Veterans Integrated Service Network 7 awarded a $1.41 million definitive contract to RLS (USA) Inc. for somatostatin receptor PET radiopharmaceuticals on July 1, 2024, under a total small business set-aside.
The originating solicitation called for daily delivery of somatostatin receptor PET radiopharmaceutical to the Nuclear Medicine Service at the Atlanta VA Health Care System. Place of performance is Decatur, GA. The contract carries a firm fixed price structure with a base year plus four one-year options, with ultimate completion date of June 30, 2029.
RLS (USA) Inc. operates as a radiopharmacy company specializing in time-sensitive nuclear medicine diagnostic agents including gallium-67, fluorodeoxyglucose F-18, thallium-201, indium-111, and Gallium-68 Dotatate (NETSPOT). The solicitation specified NAICS 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees.
Quick answers
Who was awarded contract 36C24724C0060?
36C24724C0060 was awarded to RLS (USA) Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on July 1, 2024.
How much is contract 36C24724C0060 worth?
The government has obligated $508,751 on 36C24724C0060. Its current value, with exercised options, is $810,551. Its potential value, with all options, is $1,414,152.
Was contract 36C24724C0060 competed?
The extent of competition for 36C24724C0060 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award